The global vascular imaging market is projected to reach USD 4.54 billion by 2030 from USD 3.19 billion in 2025, at a CAGR of 7.3% from 2025 to 2030. The increasing worldwide burden of cardiovascular illnesses, such as peripheral artery disease, coronary artery disease, and stroke, which is caused by lifestyle-related risk factors like smoking, obesity, diabetes, and hypertension, is the main factor driving the vascular imaging market.
Additionally, the integration of digital and cloud-based solutions for image management, government initiatives supporting early diagnosis, and the growing use of imaging in treatment planning and surgical navigation further accelerate market expansion. Key players in the vascular imaging market include Philips Healthcare (Netherlands), GE Healthcare (US), and Siemens Healthineers (Germany), among others.
To know about the assumptions considered for the study download the pdf brochure
Siemens Healthineers (Germany) holds a strong position in the vascular imaging market through its innovative imaging systems, advanced visualization software, and AI-powered diagnostic tools that support precise assessment of vascular conditions. The company’s portfolio includes cutting-edge technologies such as the SOMATOM CT scanners, MAGNETOM MRI systems, and the Artis angiography platform, all designed to deliver high-resolution vascular images with exceptional clarity. Siemens’ AI-Rad Companion and syngo.via platforms enhance image reconstruction, automate vessel analysis, and provide 3D/4D visualization for improved diagnostic accuracy and workflow efficiency. Additionally, Siemens Healthineers’ focus on digitalization, minimally invasive image-guided procedures, and integration with its teamplay cloud-based ecosystem enables data-driven decision-making and personalized vascular care, reinforcing its leadership in the global vascular imaging market.
GE Healthcare (US) plays a significant role in the vascular imaging market through its advanced portfolio of imaging systems, software, and AI-driven solutions designed to enhance vascular diagnosis and treatment planning. The company offers a wide range of technologies, including CT, MRI, and ultrasound systems—such as the Revolution CT, LOGIQ E10, and SIGNA MRI platforms—optimized for high-resolution vascular imaging and detailed visualization of blood vessels. GE HealthCare’s Edison AI platform and advanced post-processing software enable automated vessel analysis, plaque characterization, and 3D/4D reconstruction, improving diagnostic accuracy and workflow efficiency. Furthermore, its focus on integrated, cloud-based solutions and precision imaging enables clinicians to manage cardiovascular and peripheral vascular diseases more effectively, reinforcing GE HealthCare’s strong position in the global vascular imaging market.
Philips Healthcare (Netherlands) is a key player in the vascular imaging market, offering a comprehensive range of imaging systems and intelligent software solutions that enhance vascular diagnostics, treatment planning, and image-guided interventions. The company’s portfolio includes advanced technologies such as the Philips Azurion image-guided therapy platform, the IntelliSpace Portal for 3D/4D image visualization and analysis, and high-resolution modalities like the Ingenia MRI and IQon Spectral CT systems. Leveraging AI and automation through its Precision Diagnosis ecosystem, Philips enables accurate vessel quantification, plaque assessment, and real-time visualization during minimally invasive procedures. Additionally, its emphasis on interoperability, workflow integration, and cloud-based data sharing through platforms like HealthSuite positions Philips as a leader in delivering efficient, patient-centered vascular imaging solutions.
Market Ranking
The vascular imaging market is moderately fragmented but primarily led by three major players, Siemens Healthineers, GE Healthcare, and Philips Healthcare, who dominate with extensive product portfolios and strong global presence. Siemens Healthineers holds the largest market share, driven by its comprehensive range of AI-powered imaging systems and advanced ultrasound solutions that enhance diagnostic accuracy, workflow efficiency, and clinical decision-making. GE Healthcare, with the second-largest share of around 20–25%, leverages its wide global network and robust R&D in AI-enabled imaging technologies to deliver high-performance vascular imaging solutions across hospitals and clinics. Philips Healthcare follows closely, holding 10–15% of the market, offering intelligent ultrasound platforms such as EPIQ, Affiniti, and Lumify that integrate AI for automated measurements, improved image quality, and optimized clinical workflows. Other notable participants include Fujifilm Sonosite, Shimadzu, and Samsung Medison, while the remaining 5–10% of the market is captured by emerging startups and regional players focusing on AI, mobility, and cost-effective innovations.
Related Reports:
Vascular Imaging Market by Technology (MRI, Ultrasound, CT, Hybrid, OCT), Application (Atherosclerosis, DVT, Vasculitis, Aneurysmal Disorders, AV Malformations, Tumours, Others), End User (Hospitals, Diagnostic Imaging Centers) - Global Forecast to 2030
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE